Epiomic Epidemiology Series: Multiple Myeloma Forecast in 18 Major Markets 2016-2026
Introduction
Cause of the Disease
Risk Factors & Prevention
Diagnosis of the Disease
Variation by Geography/Ethnicity
Disease Prognosis & Clinical Course
Key Co-morbid Conditions/ Features Associated with the Disease
Methodology for Quantification of Patient Numbers
Top-Line Incidence for Multiple Myeloma (MM)
Staging of Multiple Myeloma Patients
Features of Multiple Myeloma Patients
Histopathology classification of MM patients
Severity of Bone Lesions in MM patients
Type of Immunoglobulin / Monoclonal Protein Type in MM patients
Co-morbid Conditions Associated with Multiple Myeloma
Abbreviations used in the Report
Other Black Swan Analysis Publications
Black Swan Analysis Online Patient-Based Databases
Patient-Based Offering
Online Pricing Data and Platforms
References
Appendix
Cause of the Disease
Risk Factors & Prevention
Diagnosis of the Disease
Variation by Geography/Ethnicity
Disease Prognosis & Clinical Course
Key Co-morbid Conditions/ Features Associated with the Disease
Methodology for Quantification of Patient Numbers
Top-Line Incidence for Multiple Myeloma (MM)
Staging of Multiple Myeloma Patients
Features of Multiple Myeloma Patients
Histopathology classification of MM patients
Severity of Bone Lesions in MM patients
Type of Immunoglobulin / Monoclonal Protein Type in MM patients
Co-morbid Conditions Associated with Multiple Myeloma
Abbreviations used in the Report
Other Black Swan Analysis Publications
Black Swan Analysis Online Patient-Based Databases
Patient-Based Offering
Online Pricing Data and Platforms
References
Appendix
LIST OF TABLES
Durie-Salmon staging for MM
International Staging System for MM
Incidence of MM, total (000s)
Incidence of MM, males (000s)
Incidence of MM, females (000s)
MM patients by stage – Durie-Salmon Staging system, total (000s)
MM patients by stage – International Staging System, total (000s)
Major Hystopathological types of MM patients, total (000s)
Severity of bone lesions by type of MM patients, total (000s)
Type of Ig / Monoclonal Proteins of MM patients, total (000s)
Prevalence of Anaemia (10g/dL) in MM patients, total (000s)
Prevalence Renal Failure at diagnosis in MM patients, total (000s)
Prevalence of BMPC ( ≥33 %) in MM patients, total (000s)
Prevalence of Elevated C- reactive protein (≥ 0.8mg/dL) in MM patients, total (000s)
Prevalence of Thrombocytopenia in MM patients, total (000s)
Prevalence of Hypercalcaemia in MM patients, total (000s)
Abbreviations and Acronyms used in the report
USA Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
USA Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
France Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
France Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Germany Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Germany Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Italy Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Italy Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Spain Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Spain Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
UK Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
UK Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Ireland Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Ireland Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Japan Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Japan Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
India Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
India Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Saudi Arabia Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Saudi Arabia Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
South Africa Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
South Africa Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Canada Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Canada Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Mexico Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Mexico Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Turkey Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Turkey Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Australia Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Australia Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Argentina Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Argentina Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Russia Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Russia Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Brazil Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Brazil Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Durie-Salmon staging for MM
International Staging System for MM
Incidence of MM, total (000s)
Incidence of MM, males (000s)
Incidence of MM, females (000s)
MM patients by stage – Durie-Salmon Staging system, total (000s)
MM patients by stage – International Staging System, total (000s)
Major Hystopathological types of MM patients, total (000s)
Severity of bone lesions by type of MM patients, total (000s)
Type of Ig / Monoclonal Proteins of MM patients, total (000s)
Prevalence of Anaemia (10g/dL) in MM patients, total (000s)
Prevalence Renal Failure at diagnosis in MM patients, total (000s)
Prevalence of BMPC ( ≥33 %) in MM patients, total (000s)
Prevalence of Elevated C- reactive protein (≥ 0.8mg/dL) in MM patients, total (000s)
Prevalence of Thrombocytopenia in MM patients, total (000s)
Prevalence of Hypercalcaemia in MM patients, total (000s)
Abbreviations and Acronyms used in the report
USA Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
USA Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
France Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
France Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Germany Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Germany Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Italy Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Italy Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Spain Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Spain Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
UK Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
UK Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Ireland Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Ireland Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Japan Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Japan Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
India Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
India Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Saudi Arabia Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Saudi Arabia Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
South Africa Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
South Africa Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Canada Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Canada Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Mexico Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Mexico Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Turkey Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Turkey Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Australia Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Australia Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Argentina Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Argentina Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Russia Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Russia Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
Brazil Incidence of Multiple Myeloma by 5-yr age cohort, males (000s)
Brazil Incidence of Multiple Myeloma by 5-yr age cohort, females (000s)
